CytomX Therapeutics, Inc. (CTMX) Stock Price History
Historical prices from 2015 to 2026
Loading 10-year price history...
Historical Performance
Short-Term Returns
CTMX Stock Price Trajectory (2015–2026)
As of March 1, 2026, CytomX Therapeutics, Inc. (CTMX) trades at $5.37, representing a +693.0% return over the past year. The stock has delivered a -8.7% return over five years, reflecting challenging market conditions.
The stock reached its all-time high of $35.00 on March 8, 2018. From this peak, CTMX has corrected -84.7%, currently trading 60% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers REGN (+11.9% 1Y), CNTA (+72.7% 1Y), and IMNM (+132.6% 1Y), CTMX has outperformed the peer group average. Compare CTMX vs REGN →
Historical Price Data
Showing 30 of 2,613 records| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-02-27 | 5.39 | 5.43 | 5.29 | 5.37 | 5 | -2.01% |
| 2026-02-26 | 5.73 | 5.73 | 5.32 | 5.48 | 5 | -5.19% |
| 2026-02-25 | 5.49 | 6.10 | 5.48 | 5.78 | 5 | +6.25% |
| 2026-02-24 | 5.56 | 5.73 | 5.44 | 5.44 | 5 | -2.51% |
| 2026-02-23 | 5.41 | 5.66 | 5.40 | 5.58 | 5 | +2.76% |
| 2026-02-20 | 5.34 | 5.55 | 5.33 | 5.43 | 5 | -0.73% |
| 2026-02-19 | 5.37 | 5.61 | 5.23 | 5.47 | 1.62M | +1.11% |
| 2026-02-18 | 5.27 | 5.42 | 5.19 | 5.41 | 3.92M | +2.85% |
| 2026-02-17 | 5.45 | 5.45 | 5.11 | 5.26 | 104K | -1.13% |
| 2026-02-13 | 5.45 | 5.65 | 5.30 | 5.32 | 3.67M | -2.03% |
| 2026-02-12 | 5.54 | 5.56 | 5.35 | 5.43 | 1.87M | -2.34% |
| 2026-02-11 | 5.56 | 5.65 | 5.20 | 5.56 | 5.18M | +0.54% |
| 2026-02-10 | 5.70 | 5.78 | 5.44 | 5.53 | 5.25M | -2.98% |
| 2026-02-09 | 5.70 | 6.00 | 5.56 | 5.70 | 2.78M | +0.53% |
| 2026-02-06 | 5.30 | 5.78 | 5.30 | 5.67 | 3.60M | +8.21% |
| 2026-02-05 | 5.62 | 5.85 | 5.17 | 5.24 | 2.76M | -7.58% |
| 2026-02-04 | 6.19 | 6.35 | 5.49 | 5.67 | 4.65M | -6.59% |
| 2026-02-03 | 6.12 | 6.17 | 5.82 | 6.07 | 2.66M | -0.33% |
| 2026-02-02 | 5.57 | 6.12 | 5.57 | 6.09 | 4.32M | +7.03% |
| 2026-01-30 | 5.69 | 5.88 | 5.38 | 5.69 | 2.08M | -0.87% |
| 2026-01-29 | 5.88 | 6.14 | 5.65 | 5.74 | 1.80M | -2.71% |
| 2026-01-28 | 5.91 | 6.11 | 5.60 | 5.90 | 3.94M | -0.51% |
| 2026-01-27 | 5.30 | 5.96 | 5.30 | 5.93 | 5.29M | +11.05% |
| 2026-01-26 | 5.50 | 5.56 | 5.26 | 5.34 | 2.31M | -3.61% |
| 2026-01-24 | 5.69 | 5.70 | 5.40 | 5.54 | 2.88M | 0.00% |
| 2026-01-23 | 5.69 | 5.70 | 5.40 | 5.54 | 3.03M | -3.15% |
| 2026-01-22 | 5.36 | 6.15 | 5.32 | 5.72 | 5.80M | +8.13% |
| 2026-01-21 | 5.28 | 5.42 | 5.04 | 5.29 | 2.37M | -1.49% |
| 2026-01-20 | 5.46 | 5.61 | 5.10 | 5.37 | 4.89M | -0.37% |
| 2026-01-16 | 4.25 | 5.70 | 4.25 | 5.39 | 13.40M | +26.82% |
See CTMX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CTMX Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare CTMX vs AGIO
See how CTMX stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
How has CTMX stock performed recently?
CTMX returned +693.0% over the past year, beating its 5-year annualized CAGR of -8.7%. The stock trades above its 200-day moving average, confirming the uptrend.
What is CTMX's all-time high price?
CytomX Therapeutics, Inc. reached $35.00 on 2018-03-08. The 52-week high is $6.35. Current 1-year return of +693.0% places the stock closer to historical peaks.
Where can I download CTMX historical price data?
This page provides CTMX daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2015-2026, downloadable in CSV format.